FDA Brief

Warning letters Food

FDA warning letter to

CC Pollen Company

High riskIssued Jan 9Posted Feb 3Human Foods Program

FDA warns CC Pollen Company of Glendale, Arizona, that its bee pollen and royal jelly supplements are adulterated and misbranded.

What happened

FDA inspected the company's Glendale, Arizona facility from April 7 to April 14, 2025 and found violations of the current good manufacturing practice (CGMP) rules for dietary supplements. Investigators found no finished-product specifications, no approved raw ingredient specifications, use of a silica lot that failed its identity test, no written master manufacturing record, and no identity testing of bee pollen before use. FDA also reviewed the product labels collected during the inspection and found the Royal Jelly serving size was wrong.

What FDA found

  1. The company never set finished-product specifications for identity, purity, strength, and composition for its Bee Pollen Granules or Royal Jelly capsules.

    21 CFR 111.70(e)
  2. The quality control unit did not document approval or rejection of the raw ingredient specifications for domestic and foreign bee pollen.

    21 CFR 111.105(a)
  3. A silica lot scored 80.37 on an identity test, below the required 85, but was still approved and used to make Royal Jelly capsules.

    21 CFR 111.77(b)
  4. The company did not prepare a written master manufacturing record, the batch recipe document, for a product it made.

    21 CFR 111.205(a)
  5. Bee pollen lots were used in manufacturing without any test to confirm the ingredient's identity first.

    21 CFR 111.75(a)(1)(i)
  6. The Royal Jelly label lists a serving size of one capsule, but the directions say to take one to two capsules.

    Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)]

What FDA wants

FDA asks the company to write back within 15 working days of receiving the letter with the specific steps taken to fix each violation, documents supporting those steps, and how it will prevent them from happening again.

Who should pay attention

  • retailers and online sellers that stock bee pollen and royal jelly supplements
  • brands and contract manufacturers that rely on raw ingredient identity testing
  • suppliers of bulk bee pollen and royal jelly

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Penn Herb Company, Ltd.

    FDA warned Penn Herb Company over CGMP violations and an undeclared tree-nut allergen in three dietary supplements.

    High risk
  2. Psyched Wellness Ltd.

    FDA warned Psyched Wellness that its Calm, Calmer and Santa Amanita muscaria supplements are adulterated new-dietary-ingredient products.

    High risk
  3. Wellmill, LLC dba Vitamix Laboratories

    FDA warned Vitamix Laboratories that its juice-with-probiotics products were adulterated because it lacked required hazard controls and a 5-log pathogen reduction.

    High risk
  4. American Pharma Mfg. Inc.

    FDA warns American Pharma Mfg. of serious dietary supplement manufacturing violations at its Ontario, CA facility.

    High risk